195 related articles for article (PubMed ID: 26386941)
1. Repeated or intermittent levosimendan treatment in advanced heart failure: An updated meta-analysis.
Silvetti S; Nieminen MS
Int J Cardiol; 2016 Jan; 202():138-43. PubMed ID: 26386941
[TBL] [Abstract][Full Text] [Related]
2. Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Pölzl G; Altenberger J; Baholli L; Beltrán P; Borbély A; Comin-Colet J; Delgado JF; Fedele F; Fontana A; Fruhwald F; Giamouzis G; Giannakoulas G; Garcia-González MJ; Gustafsson F; Kaikkonen K; Kivikko M; Kubica J; von Lewinski D; Löfman I; Malfatto G; Manito N; Martínez-Sellés M; Masip J; Merkely B; Morandi F; Mølgaard H; Oliva F; Pantev E; Papp Z; Perna GP; Pfister R; Piazza V; Bover R; Rangel-Sousa D; Recio-Mayoral A; Reinecke A; Rieth A; Sarapohja T; Schmidt G; Seidel M; Störk S; Vrtovec B; Wikström G; Yerly P; Pollesello P
Int J Cardiol; 2017 Sep; 243():389-395. PubMed ID: 28571618
[TBL] [Abstract][Full Text] [Related]
3. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus.
Nieminen MS; Altenberger J; Ben-Gal T; Böhmer A; Comin-Colet J; Dickstein K; Edes I; Fedele F; Fonseca C; García-González MJ; Giannakoulas G; Iakobishvili Z; Jääskeläinen P; Karavidas A; Kettner J; Kivikko M; Lund LH; Matskeplishvili ST; Metra M; Morandi F; Oliva F; Parkhomenko A; Parissis J; Pollesello P; Pölzl G; Schwinger RH; Segovia J; Seidel M; Vrtovec B; Wikström G
Int J Cardiol; 2014 Jun; 174(2):360-7. PubMed ID: 24780540
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis.
Gong B; Li Z; Yat Wong PC
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1415-25. PubMed ID: 26275522
[TBL] [Abstract][Full Text] [Related]
5. Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta-analysis of randomized trials.
Silvetti S; Belletti A; Fontana A; Pollesello P
ESC Heart Fail; 2017 Nov; 4(4):595-604. PubMed ID: 28834396
[TBL] [Abstract][Full Text] [Related]
6. Planned repetitive use of levosimendan for heart failure in cardiology and internal medicine in Sweden.
Thorvaldsen T; Benson L; Hagerman I; Dahlström U; Edner M; Lund LH
Int J Cardiol; 2014 Jul; 175(1):55-61. PubMed ID: 24820737
[TBL] [Abstract][Full Text] [Related]
7. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials.
Silvetti S; Greco T; Di Prima AL; Mucchetti M; de Lurdes CM; Pasin L; Scandroglio M; Landoni G; Zangrillo A
Clin Res Cardiol; 2014 Jul; 103(7):505-13. PubMed ID: 24368740
[TBL] [Abstract][Full Text] [Related]
8. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan: a new dual-action drug in the treatment of acute heart failure.
Mebazaa A; Erhardt L
Int J Clin Pract; 2003 Jun; 57(5):410-6. PubMed ID: 12846347
[TBL] [Abstract][Full Text] [Related]
10. Inotropic agents in advanced heart failure: repetita iuvant?
De Luca L
Int J Cardiol; 2014 Sep; 176(1):6-7. PubMed ID: 25065330
[No Abstract] [Full Text] [Related]
11. Assessment of quality of life using three activity questionnaires in heart failure patients after monthly, intermittent administration of levosimendan during a six-month period.
Papadopoulou EF; Mavrogeni SI; Dritsas A; Cokkinos DV
Hellenic J Cardiol; 2009; 50(4):269-74. PubMed ID: 19622496
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan meta-analyses: Is there a pattern in the effect on mortality?
Pollesello P; Parissis J; Kivikko M; Harjola VP
Int J Cardiol; 2016 Apr; 209():77-83. PubMed ID: 26882190
[TBL] [Abstract][Full Text] [Related]
13. Repetitive infusion of levosimendan in patients with chronic heart failure: a meta-analysis.
Yi GY; Li JX; Zhang J; Niu LL; Zhang CY
Med Sci Monit; 2015 Mar; 21():895-901. PubMed ID: 25811545
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure.
Cleland JG; Nikitin N; McGowan J
Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):9-19. PubMed ID: 15038409
[TBL] [Abstract][Full Text] [Related]
15. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
Parle NM; Thomas MD; Dembo L; Best M; Driscoll GO
Heart Lung Circ; 2008 Jun; 17(3):206-10. PubMed ID: 18242130
[TBL] [Abstract][Full Text] [Related]
16. Peripartum cardiomyopathy: a new successful setting for levosimendan.
Benezet-Mazuecos J; de la Hera J
Int J Cardiol; 2008 Jan; 123(3):346-7. PubMed ID: 17324479
[No Abstract] [Full Text] [Related]
17. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.
García-González MJ; de Mora-Martín M; López-Fernández S; López-Díaz J; Martínez-Sellés M; Romero-García J; Cordero M; Lara-Padrón A; Marrero-Rodríguez F; del Mar García-Saiz M; Aldea-Perona A;
Cardiovasc Drugs Ther; 2013 Dec; 27(6):573-9. PubMed ID: 23887741
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the clinical, hemodynamic and neurohormonal response to levosimendan administration in decompensated heart failure patients. One-month follow-up.
Sargento L; Brito D; Matias JS; Madeira H
Rev Port Cardiol; 2007; 26(7-8):717-26. PubMed ID: 17939581
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction.
Jia Z; Guo M; Zhang YQ; Liang HQ; Zhang LY; Song Y
Cardiology; 2014; 128(2):195-201. PubMed ID: 24751462
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan reduces heart failure after cardiac surgery: a prospective, randomized, placebo-controlled trial.
Lahtinen P; Pitkänen O; Pölönen P; Turpeinen A; Kiviniemi V; Uusaro A
Crit Care Med; 2011 Oct; 39(10):2263-70. PubMed ID: 21666445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
